Thursday, July 25, 2013

Orion, Mylan settle patent dispute over Parkinson's drug Stalevo

Orion, Mylan settle patent dispute over Parkinson's drug Stalevo

HELSINKI | Thu Jul 25, 2013 5:50am EDT

(Reuters) - Finnish drug maker Orion said that it settled a patent lawsuit in the United States against Mylan Pharmaceuticals over Mylan's application to sell a generic version of Orion's Parkinson's drug Stalevo.

Orion did not disclose the terms of their settlement, but said Mylan would be authorized to launch generic versions of the Stalevo drug.

(Reporting by Ritsuko Ando; editing by Keiron Henderson)

This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers. Five Filters recommends: 'You Say What You Like, Because They Like What You Say' - http://www.medialens.org/index.php/alerts/alert-archive/alerts-2013/731-you-say-what-you-like-because-they-like-what-you-say.html

Posted by at